Tumour – Vestibular schwannomas 2
Time after vestibular schwannoma treatment: Annual risk of tumor recurrence after radiosurgery or microsurgery
Expression of MSR1 identifies M2 macrophages in vestibular schwannomas and is associated with higher proliferation
Genetic influence, individual genetic profiling and targetable treatment in patients with NF2-associated vestibular schwannomas
High prognostic impact of preoperative FDG PET uptake and MIB-1 index in MPNST tumors with and without association to NF1 disease
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma
Widening of the internal acoustic meatus is a factor for poor preoperative hearing in vestibular schwannoma independent of preaoperative tumor size